{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:20:29Z","timestamp":1789989629604,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.rmr.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T19:13:25Z","timestamp":1525374805000},"page":"390-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Les chambres d\u2019exposition environnementale (CEE)\u00a0: un nouvel outil dans la recherche acad\u00e9mique et industrielle"],"prefix":"10.1016","volume":"35","author":[{"given":"N.","family":"Khayath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Choual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vecellio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Domis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"De Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2018.01.005_bib0215","doi-asserted-by":"crossref","DOI":"10.1038\/35037000","article-title":"The epidemic of allergy and asthma","volume":"402","author":"Holgate","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.rmr.2018.01.005_bib0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM200101043440106","article-title":"Allergy and allergic diseases. First of two parts","volume":"344","author":"Kay","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2018.01.005_bib0225","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1586\/1744666X.2014.955476","article-title":"Current recommendations and emerging options for the treatment of allergic rhinitis","volume":"10","author":"Licari","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0230","first-page":"2","article-title":"Epidemiology and natural history of atopic diseases","author":"Thomsen","year":"2015","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.rmr.2018.01.005_bib0235","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaci.2013.08.023","article-title":"Inhaled allergen bronchoprovocation tests","volume":"132","author":"Diamant","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1398-9995.1997.tb04814.x","article-title":"Provocation tests with allergens","volume":"52","author":"Melillo","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2018.01.005_bib0245","series-title":"Experimental research on the causes and nature of Catharrus aestivus (Hay fever or Hay asthma)","author":"Blackley","year":"1873"},{"key":"10.1016\/j.rmr.2018.01.005_bib0250","volume":"1","author":"Spector","year":"1983"},{"key":"10.1016\/j.rmr.2018.01.005_bib0255","first-page":"829","article-title":"Bronchial provocation tests in etiologic diagnosis and analysis of asthma","volume":"112","author":"Pepys","year":"1975","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmr.2018.01.005_bib0260","first-page":"310","article-title":"Les test de provocation bronchiqe dans l\u2019asthme correspondent-ils \u00e0 la r\u00e9alit\u00e9\u00a0?","volume":"43","author":"Lieutier-Colas","year":"2003","journal-title":"Rev Fr Allergol Immunol Clin"},{"key":"10.1016\/j.rmr.2018.01.005_bib0265","first-page":"509","article-title":"Die Wiener Provokations-kammer (Vienna Challenge Chamber). Eine neue methode des Allergene expositions tests","volume":"99","author":"Horak","year":"1987","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.rmr.2018.01.005_bib0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2222.2008.03172.x","article-title":"Provoked models of asthma: what have we learnt?","volume":"39","author":"O\u2019Byrne","year":"2009","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0275","series-title":"Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases","author":"Committee for Medicinal Products for Human Use","year":"2008"},{"key":"10.1016\/j.rmr.2018.01.005_bib0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1398-9995.2010.02473.x","article-title":"The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy","volume":"66","author":"Devillier","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2018.01.005_bib0285","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11882-016-0659-9","article-title":"How in vitro assays contribute to allergy diagnosis","volume":"16","author":"Casset","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.rmr.2018.01.005_bib0290","series-title":"Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases","author":"Agence europ\u00e9enne de m\u00e9decine","year":"2008"},{"key":"10.1016\/j.rmr.2018.01.005_bib0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2222.2005.00099.x","article-title":"The role of allergen challenge chambers in the evaluation of anti-allergic medication: an international consensus paper","volume":"6","author":"Day","year":"2006","journal-title":"Clin Exp Allergy Rev"},{"key":"10.1016\/j.rmr.2018.01.005_bib0300","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaci.2014.10.045","article-title":"Environmental exposure chambers in allergen immunotherapy trials: current status and clinical validation needs","volume":"135","author":"R\u00f6sner-Friese","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0305","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1067\/mai.2002.124657","article-title":"Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit","volume":"109","author":"Horak","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0310","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1081-1206(10)61038-1","article-title":"Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber","volume":"96","author":"Stuebner","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0315","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0091-6749(87)90213-2","article-title":"Immunologic studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI) off products","volume":"79","author":"Pross","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0320","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1081-1206(10)62616-6","article-title":"Environmental exposure unit: a system to test anti-allergic treatment","volume":"83","author":"Day","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0325","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1365-2222.2003.01810.x","article-title":"Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis","volume":"33","author":"Krug","year":"2003","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000189197","article-title":"Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis","volume":"149","author":"Hashiguchi","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.anai.2011.04.009","article-title":"Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen","volume":"107","author":"Jacobs","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0340","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1398-9995.1997.tb02153.x","article-title":"Exposure chamber for allergen challenge. A placebo-controlled, double-blind trial in house-dust-mite asthma","volume":"52","author":"R\u00f8nborg","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2018.01.005_bib0345","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0091-6749(98)70172-1","article-title":"Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit","volume":"101","author":"Day","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0350","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62260-0","article-title":"Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system","volume":"87","author":"Day","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0355","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1365-2222.2010.03498.x","article-title":"Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions","volume":"40","author":"Hohlfeld","year":"2010","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0360","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaci.2012.03.031","article-title":"Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes","volume":"130","author":"Jacobs","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0365","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.anai.2010.01.012","article-title":"Factors that affect the allergic rhinitis response to ragweed allergen exposure","volume":"104","author":"Ellis","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0370","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1164\/rccm.2204037","article-title":"Bronchial challenge tests in patients with asthma sensitized to cats: the importance of large particles in the immediate response","volume":"167","author":"Lieutier-Colas","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2018.01.005_bib0375","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/jam.2007.0591","article-title":"Bronchial challenge test in asthmatics sensitized to mites: role of particle size in bronchial response","volume":"20","author":"Casset","year":"2007","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.rmr.2018.01.005_bib0380","series-title":"Allergic rhinitis: clinical development programs for drug products","author":"Center for Drug Evaluation Research Food Drug Administration D. of HHS","year":"2000"},{"key":"10.1016\/j.rmr.2018.01.005_bib0385","series-title":"Guideline on the clinical development of medicinal products for the treatment of allergic rhinoconjunctivitis","author":"Committee for medicinal products for human use European Medicines Agency","year":"2004"},{"key":"10.1016\/j.rmr.2018.01.005_bib0390","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1398-9995.2004.00577.x","article-title":"The ARIA\/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine","volume":"59","author":"Bousquet","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2018.01.005_bib0395","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaci.2009.06.006","article-title":"Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber","volume":"124","author":"Horak","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2018.01.005_bib0400","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2332\/allergolint.10-OA-0264","article-title":"Evaluating the effects of testing period on pollinosis symptoms using an allergen challenge chamber","volume":"60","author":"Yuki","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.rmr.2018.01.005_bib0405","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5414\/CPP47071","article-title":"A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis","volume":"47","author":"Badorrek","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.rmr.2018.01.005_bib0410","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1398-9995.2005.00703.x","article-title":"Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit","volume":"60","author":"Krug","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2018.01.005_bib0415","doi-asserted-by":"crossref","unstructured":"Pfaar O, Calderon M, Andrews CP, Angjeli E, Bergmann K, B\u00f8nl\u00f8kke JH, et al. Allergen Exposure Chamber (AEC): harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper. Allergy 72, 2017, 1035-1042.","DOI":"10.1111\/all.13133"},{"key":"10.1016\/j.rmr.2018.01.005_bib0420","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/all.12383","article-title":"Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI position paper","volume":"69","author":"Pfaar","year":"2014","journal-title":"Allergy"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518300081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518300081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T08:51:27Z","timestamp":1571302287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842518300081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0761842518300081"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2018.01.005","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les chambres d\u2019exposition environnementale (CEE)\u00a0: un nouvel outil dans la recherche acad\u00e9mique et industrielle","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS on behalf of SPLF.","name":"copyright","label":"Copyright"}]}}